Dr. Bacon's research deals with the impact of health behaviours and lifestyle (e.g., physical activity, diet, weight management, stress) on chronic diseases (e.g., obesity, cardiovascular disease, and chronic lung disease), as well as COVID-19 related mitigation behaviours. He utilises multiple methodologies including epidemiological, psychophysiological, systematic review, and behavioural trials designs. Currently, Dr. Bacon is the CIHR SPOR Mentoring Chair in Innovative, Patient-Oriented, Behavioural Clinical Trials and a fellow of the Obesity Society, the Canadian Cardiovascular Society, and the Academy of Behavioral Medicine Research. Prior to joining Concordia he completed his postdoctoral studies at the Duke University Medical Center, McGill University, Hôpital du Sacré-Coeur de Montréal, and the Montreal Heart Institute. In addition to Concordia, Dr. Bacon is co-director of the Montreal Behavioural Medicine Centre (www.mbmc-cmcm.ca), a researcher at the Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS-NIM: ciusss-nordmtl.gouv.qc.ca/votre-ciusss/centres-de-recherche/), and co-leads the International Behavioural Trials Network (www.IBTNetwork.org).
The first line of vaccines was highly effective at restricting COVID-19’s damage
Jun 01, 2023 11:33 am UTC| Health
After more than three years of COVID-19, the World Health Organization (WHO) reports that over 763 million infections, and nearly seven million deaths, have been attributed to SARS-CoV-2. COVID-19 vaccination was deemed...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight